99 related articles for article (PubMed ID: 21920010)
1. The impact of the two-week wait referral pathway on rectal cancer survival.
Currie AC; Evans J; Smith NJ; Brown G; Abulafi AM; Swift RI
Colorectal Dis; 2012 Jul; 14(7):848-53. PubMed ID: 21920010
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
3. Preoperative tumour staging with multidisciplinary team assessment improves the outcome in locally advanced primary rectal cancer.
Palmer G; Martling A; Cedermark B; Holm T
Colorectal Dis; 2011 Dec; 13(12):1361-9. PubMed ID: 20958913
[TBL] [Abstract][Full Text] [Related]
4. The "two-week wait" referral pathway allows prompt treatment but does not improve outcome for patients with oesophago-gastric cancer.
Sharpe D; Williams RN; Ubhi SS; Sutton CD; Bowrey DJ
Eur J Surg Oncol; 2010 Oct; 36(10):977-81. PubMed ID: 20702059
[TBL] [Abstract][Full Text] [Related]
5. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
6. Outcomes in locally advanced rectal cancer with highly selective preoperative chemoradiotherapy.
Williamson JS; Jones HG; Davies M; Evans MD; Hatcher O; Beynon J; Harris DA;
Br J Surg; 2014 Sep; 101(10):1290-8. PubMed ID: 24924947
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes.
Gollins S; Sun Myint A; Haylock B; Wise M; Saunders M; Neupane R; Essapen S; Samuel L; Dougal M; Lloyd A; Morris J; Topham C; Susnerwala S
J Clin Oncol; 2011 Mar; 29(8):1042-9. PubMed ID: 21263095
[TBL] [Abstract][Full Text] [Related]
8. Ratio of metastatic lymph nodes is more important for rectal cancer patients treated with preoperative chemoradiotherapy.
Park IJ; Yu CS; Lim SB; Yoon YS; Kim CW; Kim TW; Kim JH; Kim JC
World J Gastroenterol; 2015 Mar; 21(11):3274-81. PubMed ID: 25805934
[TBL] [Abstract][Full Text] [Related]
9. Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort study.
Li J; Liu H; Yin J; Liu S; Hu J; Du F; Yuan J; Lv B; Fan J; Leng S; Zhang X
Oncotarget; 2015 Dec; 6(39):42354-61. PubMed ID: 26472284
[TBL] [Abstract][Full Text] [Related]
10. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
[TBL] [Abstract][Full Text] [Related]
11. Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).
Dewdney A; Cunningham D; Tabernero J; Capdevila J; Glimelius B; Cervantes A; Tait D; Brown G; Wotherspoon A; Gonzalez de Castro D; Chua YJ; Wong R; Barbachano Y; Oates J; Chau I
J Clin Oncol; 2012 May; 30(14):1620-7. PubMed ID: 22473163
[TBL] [Abstract][Full Text] [Related]
12. Prospective controlled study of the safety and oncological outcomes of ELAPE procure with definitive anatomic landmarks versus conventional APE for lower rectal cancer.
Shen Z; Ye Y; Zhang X; Xie Q; Yin M; Yang X; Jiang K; Liang B; Wang S
Eur J Surg Oncol; 2015 Apr; 41(4):472-7. PubMed ID: 25659773
[TBL] [Abstract][Full Text] [Related]
13. Short-term results and long-term oncologic outcomes between neoadjuvant chemoradiotherapy and adjuvant postoperative chemoradiotherapy for stage III rectal cancer: a case-matched study.
Kang J; Jang SM; Baek JH; Lee WS; Cho TH
Ann Surg Oncol; 2012 Aug; 19(8):2494-9. PubMed ID: 22476817
[TBL] [Abstract][Full Text] [Related]
14. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome.
Wolthuis AM; Penninckx F; Haustermans K; De Hertogh G; Fieuws S; Van Cutsem E; D'Hoore A
Ann Surg Oncol; 2012 Sep; 19(9):2833-41. PubMed ID: 22451236
[TBL] [Abstract][Full Text] [Related]
15. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB
Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654
[TBL] [Abstract][Full Text] [Related]
16. Impression of prognosis regarding pathologic stage after preoperative chemoradiotherapy in rectal cancer.
Hwang K; Park IJ; Yu CS; Lim SB; Lee JL; Yoon YS; Kim CW; Kim JC
World J Gastroenterol; 2015 Jan; 21(2):563-70. PubMed ID: 25593475
[TBL] [Abstract][Full Text] [Related]
17. Oncologic outcomes and perioperative clinicopathologic results after robot-assisted tumor-specific mesorectal excision for rectal cancer.
Baik SH; Kim NK; Lim DR; Hur H; Min BS; Lee KY
Ann Surg Oncol; 2013 Aug; 20(8):2625-32. PubMed ID: 23417433
[TBL] [Abstract][Full Text] [Related]
18. The 2-week wait referral system does not improve 5-year colorectal cancer survival.
Zafar A; Mak T; Whinnie S; Chapman MA
Colorectal Dis; 2012 Apr; 14(4):e177-80. PubMed ID: 21920007
[TBL] [Abstract][Full Text] [Related]
19. Is adjuvant chemotherapy really needed after curative surgery for rectal cancer patients who are node-negative after neoadjuvant chemoradiotherapy?
Kiran RP; Kirat HT; Burgess AN; Nisar PJ; Kalady MF; Lavery IC
Ann Surg Oncol; 2012 Apr; 19(4):1206-12. PubMed ID: 21935748
[TBL] [Abstract][Full Text] [Related]
20. Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation.
Lin CY; Tian YF; Wu LC; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Wang YH; Shiue YL; Wu WR; Huang HY; Hsu HP; Li CF; Chen SH
J Clin Pathol; 2012 Aug; 65(8):687-92. PubMed ID: 22569540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
